Gilead's revenue rises 17% driven by sales of coronavirus treatment remdesivir
October 28, 2020 at 17:11 PM EDT
Remdesivir generated $873 million in sales during the third quarter, mostly in the U.S., the company said.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |